Capricor Therapeutics (CAPR) Long-Term Debt Issuances (2013 - 2018)

Capricor Therapeutics' Long-Term Debt Issuances history runs 5 years deep, the most recent figure standing at -$139140.0 for Q2 2018.

• In Q2 2018, Long-Term Debt Issuances fell 155.66% year-over-year to -$139140.0; the TTM figure through Sep 2019 stood at -$139140.0 (down 155.66% YoY), while the FY2020 annual figure was $318160.0, changed N/A from the prior year.
• Long-Term Debt Issuances for Q2 2018 stood at -$139140.0, down from $139140.0 in the prior quarter.
• The five-year high for Long-Term Debt Issuances was $2.0 million in Q2 2016, with the low at -$139140.0 in Q2 2018.
• The 4-year median for Long-Term Debt Issuances is $250000.0 (2017), against an average of $576417.7.
• The sharpest annual moves came in 2014 and 2018: Long-Term Debt Issuances tumbled 83.24% in 2014, then tumbled 155.66% in 2018.
• Capricor Therapeutics' Long-Term Debt Issuances stood at -$6667.0 in 2014, then jumped by 26348.69% to $1.8 million in 2016, then sank by 85.71% to $250000.0 in 2017, then sank by 155.66% to -$139140.0 in 2018.
• Business Quant data shows CAPR's Long-Term Debt Issuances at -$139140.0 in Q2 2018, $139140.0 in Q1 2018, and $250000.0 in Q4 2017.